Clinical experience of entirely subcutaneous implantable cardioverterdefibrillators in children and adults: Cause for caution

European Heart Journal

Volumn 33, Issue 11, 2012, Pages 1351-1359

  Jarman, Julian W E ^a   Lascelles, Karen ^a   Wong, Tom ^a   Markides, Vias ^a   Clague, Jonathan R ^a   Till, Janice ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Congenital heart disease; Implantable cardioverter defibrillator; Paediatric; Sudden cardiac death

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; DEFIBRILLATOR; DEVICE SAFETY; ELECTRODE; EXPERIENCE; FEMALE; HEART ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HIGH RISK POPULATION; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULSE GENERATOR; SCHOOL CHILD; SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; SUDDEN DEATH; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ARRHYTHMIAS, CARDIAC; CASE-CONTROL STUDIES; CHILD; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84861806592     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs017     Document Type: Article

References (22)

1. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm 2008;5:e1-e62.
2. Goette A, Cantu F, van Erven L, Geelen P, Halimi F, Merino JL, Morgan JM; Scientific Initiative Committee of the European Heart Rhythm Association. Performance and survival of transvenous defibrillation leads: need for a European data registry. Europace 2009;11:31-34.
3. Radbill AE, Triedman JK, Berul CI, Fynn-Thompson F, Atallah J, Alexander ME, Walsh EP, Cecchin F. System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverterdefibrillators in pediatric and congenital heart disease patients. Heart Rhythm 2010;7:193-198.
4. Links MS, Hill SL, Cliff DL, Swygman CA, Foote CB, Homoud MK, Wang PJ, Estes NA 3rd, Berul CI. Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults. Am J Cardiol 1999;83: 263-266, A5-6. (Pubitemid 29047310)
5. Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol 2004;15:72-76. (Pubitemid 38147223)
6. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, Van Gelder IC, Wilde AA, van Dessel PF, Knops RE, Barr CS, Lupo P, Cappato R, Grace AA. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 2010;363:36-44.
7. Dabiri Abkenari L, Theuns DA, Valk SD, Van Belle Y, de Groot NM, Haitsma D, Muskens-Heemskerk A, Szili-Torok T, Jordaens L. Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin Res Cardiol 2011 [E-pub ahead of print, 17 March], doi: 10.1007/s00392-011-0303-6.
8. Gold MR, Theuns DA, Knight BP, Sturdivant JL, Sanghera R, Ellenbogen KA, Wood MA, Burke MC. Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: The START Study. J Cardiovasc Electrophysiol 2011 [Epub ahead of print, 28 October], doi: 10.1111/j.1540-8167.2011.02199.x.
9. Burke M, Toff WD, Ludmer PL, Barr CS, Beshai JF, O'Neill PG, Lee MA, Skehan JD, Kim SS, Cho S, Kang S, Lin AC, Knight BP. Comparisons during multiple postures of resting ECG's (COMPARE) study. Heart Rhythm 2009;6:S126. (abstract).
10. Zhan C, Baine WB, Sedrakyan A, Steiner C. Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis. J Gen Intern Med 2008;23(Suppl. 1):13-19. (Pubitemid 350295396)
11. Kennergren C. A European perspective on lead extraction: part I. Heart Rhythm 2008;5:160-162.
12. Wathen MS, Sweeney MO, DeGroot PJ, Stark AJ, Koehler JL, Chisner MB, Machado C, Adkisson WO; PainFREE Investigators. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001;104:796-801. (Pubitemid 32762678)
13. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ; PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004;110: 2591-2596. (Pubitemid 39453007)
14. Klug D, Vaksmann G, Jarwé M, Wallet F, Francart C, Kacet S, Rey C. Pacemaker lead infection in young patients. Pacing Clin Electrophysiol 2003;26:1489-1493. (Pubitemid 36836700)
15. Van Rees JB, Borleffs CJ, de Bie MK, Stijnen T, van Erven L, Bax JJ, Schalij MJ. Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol 2011;57:556-562.
16. Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, Cannon BC, Alexander ME, Triedman JK, Walsh EP, Friedman RA. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008;51:1685-1691. (Pubitemid 351626414)
17. Von Bergen NH, Atkins DL, Dick M 2nd, Bradley DJ, Etheridge SP, Saarel EV, Fischbach PS, Balaji S, Sreeram N, Evans WN, Law IH. Multicenter study of the effectiveness of implantable cardioverter defibrillators in children and young adults with heart disease. Pediatr Cardiol 2011;32:399-405.
18. Botsch MP, Franzbach B, Opgen-Rhein B, Berger F, Will JC. ICD therapy in children and young adults: low incidence of inappropriate shock delivery. Pacing Clin Electrophysiol 2010;33:734-741.
19. Schwartz PJ, Spazzolini C, Priori SG, Crotti L, Vicentini A, Landolina M, Gasparini M, Wilde AA, Knops RE, Denjoy I, Toivonen L, Mö nnig G, Al-Fayyadh M, Jordaens L, Borggrefe M, Holmgren C, Brugada P, De Roy L, Hohnloser SH, Brink PA. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? Data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry. Circulation 2010;122:1272-1282.
20. Sy RW, Gollob MH, Klein GJ, Yee R, Skanes AC, Gula LJ, Leong-Sit P, Gow RM, Green MS, Birnie DH, Krahn AD. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2011;8:864-871.
21. Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-Gérard F, Mabo P, Reuter S, Lamaison D, Takahashi Y, O'Neill MD, Garrigue S, Pierre B, Jäs P, Pasquié JL, Hocini M, Salvador-Mazenq M, Nogami A, Amiel A, Defaye P, Bordachar P, Boveda S, Maury P, Klug D, Babuty D, Hässaguerre M, Mansourati J, Clémenty J, Le Marec H. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation 2006;114:2317-2324. (Pubitemid 44847448)
22. Ellenbogen KA, Edel T, Moore S, Higgins S, Pacifico A, Wilber D, Wood MA, Rogers R, Dahn A, Zhu A. A prospective randomized-controlled trial of ventricular fibrillation detection time in a DDDR ventricular defibrillator. Ventak AV II DR Study Investigators. Pacing Clin Electrophysiol 2000;23: 1268-1272. (Pubitemid 30658520)